Rojas, Elizabeta A.
Corchete, Luis A. http://orcid.org/0000-0003-4577-8599
Mateos, María Victoria
García-Sanz, Ramón http://orcid.org/0000-0003-4120-2787
Misiewicz-Krzeminska, Irena
Gutiérrez, Norma C.
Article History
Received: 4 June 2019
Revised: 17 October 2019
Accepted: 29 October 2019
First Online: 20 November 2019
Competing interests
: Dr. Mateos reports personal fees from Janssen, Celgene, Amgen, Takeda, Pharmamar, GSK, AbbVie and Adaptive, outside the submitted work. Dr. Garcia-Sanz reports personal fees from Amgen, Janssen, Takeda and Pfizer, outside the submitted work. Dr. Gutiérrez reports honoraria from Janssen outside the submitted work. The other authors declare no conflict of interest.
: This study was partially supported by the Instituto de Salud Carlos III cofinanced by the European Union FEDER funds (PI13/00111 and PI16/01074), Gerencia Regional de Salud, Junta de Castilla y León (BIO/SA57/13) and the Asociación Española Contra el Cáncer (AECC, GCB120981SAN). E.A.R.R. was supported by the Consejería de Educación de Castilla y León and FEDER funds. I.M.K. and L.A.C. were supported by the Sociedad Española de Hematología y Hemoterapia.